Drug Type Small molecule drug |
Synonyms Pancold A, 판콜에이내복액 |
Target |
Action agonists, antagonists |
Mechanism A1R agonists(Adenosine A1 receptor agonists), A2aR antagonists(Adenosine A2a receptor antagonists), H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (28 May 2025), |
Regulation- |
Molecular FormulaC26H39NO10 |
InChIKeyAKJDEXBCRLOVTH-UHFFFAOYSA-N |
CAS Registry23142-01-0 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Common Cold | South Korea | 28 May 2025 |





